Heart Disease News and Research

Latest Heart Disease News and Research

GTx reports top line results from toremifene Phase III clinical trial for prostate cancer

GTx, Inc. today announced top line results of the Phase III clinical trial evaluating toremifene 20 mg, a selective estrogen receptor modulator, for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia, or PIN, a premalignant lesion of the prostate.

26 May 2010

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

Genzyme Corporation announced today that the FDA has granted U.S. marketing approval for Lumizyme™ (alglucosidase alfa), produced at the 4000 liter (L) bioreactor scale at its manufacturing facility in Geel, Belgium. Lumizyme is the first treatment approved in the United States specifically to treat patients with late-onset Pompe disease.

25 May 2010

St. Jude Medical initiates enrollment in FAME II trial for coronary artery disease

St. Jude Medical, Inc., a global medical device company, announced today at EuroPCR that the first patient was enrolled in the FAME II (Fractional Flow Reserve (FFR)-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment vs. Optimal Medical Treatment Alone in Patients with Stable Coronary Artery Disease) trial.

25 May 2010

Medtronic fiscal year 2010 revenue up 8% to $15.817 billion

Medtronic, Inc. today announced financial results for its fourth quarter and fiscal year ended April 30, 2010.

25 May 2010

MAQUET Cardiovascular commences enrollment in trial of FUSION and FUSION BIOLINE Vascular Grafts

MAQUET Cardiovascular LLC today announced enrollment of the first patient in FINEST (FUSION Vascular Graft, FUSION Vascular Graft with BIOLINE and EXXCEL SOFT ePTFE). This prospective, randomized, single-blind, three-arm, parallel group, multi-center study is evaluating the safety and efficacy of MAQUET's investigational FUSION Vascular Graft and FUSION BIOLINE Vascular Graft, compared with its commercially available EXXCEL Soft ePTFE Vascular Graft in peripheral artery bypass surgery.

25 May 2010

REDUCE trial data published in the online version of European Urology

On 8 May an editorial about the Reduction by Dutasteride of Prostate Cancer Events trial by Fritz H. Schröder and Monique J. Roobol was published in the online version of European Urology, the scientific journal of the European Association of Urology.

25 May 2010

Anaheim Regional Medical Center uses Arctic Sun cooling device to protect a patient from brain damage

A day after delivering her fourth child at Anaheim Regional Medical Center in Anaheim, California last December, 34-year-old Brynn Ervin suffered a cardiac arrest, the result of massive blood clots lodged in the main arteries that take blood to her lungs. Desperate to save the life of the young mother, the cardiac arrest team performed 95 minutes of CPR.

25 May 2010

Hawaii Pacific Health, Saint Barnabas Health Care System and XCelience achieve CEO Cancer Gold Standard

Hawaii Pacific Health, Saint Barnabas Health Care System N.J., and XCelience LLC, have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.

25 May 2010

Researchers develop new device that can change current landscape of chronic wound management

Complex wounds affect more patients in the United States than heart attack and stroke combined, and five to seven million Americans with complex wounds account for over $20 billion in healthcare expenditures. About 150,000 amputations a year result from complex wounds, while about 80,000 are attributed to diabetes and peripheral arterial disease.

25 May 2010

Masimo PVI identifies patients at high risk for developing severe hypotension during anesthesia induction

Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new clinical study published in the May 2010 issue of Acta Anaesthesiologica Scandinavica shows that Masimo pleth variability index can be used to help clinicians assess risk for mean arterial pressure decreases and subsequent hypotension during anesthesia administration.

25 May 2010

t2c001 product obtains certificate under EMA regulations for ATMPs

t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the quality of its lead product t2c001 has been certified by the European Medicines Agency.

25 May 2010

Folate supplementation thwarts heart birth defects induced by alcohol exposure in early pregnancy

A new animal study has found that high levels of the B-vitamin folate (folic acid) prevented heart birth defects induced by alcohol exposure in early pregnancy, a condition known as fetal alcohol syndrome.

25 May 2010

EHSI reports favorable completion of due diligence with Stand-By Systems

Emerging Healthcare Solutions, Inc. disclosed today that the Company has just favorably completed the financial review phase of due diligence with Stand-By Systems. EHSI recently executed an option with Stand-By Systems; owner of the new FDA approved SBS 1615 catalytic oxygen generator, as well as the associated LIFEDGE® and MAYDAY® emergency systems. EHSI is currently performing due diligence under this option.

25 May 2010

PMI's CAAS software integrated with Ziehm Imaging's mobile cardiovascular imaging solutions

Ziehm Imaging and Pie Medical Imaging BV have joined forces to make the CAAS quantification software available on mobile C-arms dedicated for cardiovascular procedures. This capability is the result of Ziehm Imaging's strategic partnership with Pie Medical Imaging BV (PMI, Maastricht, the Netherlands), a leading developer of quantitative analysis software for cardiology and radiology.

25 May 2010

Mayo Clinic becomes first hospital in the U.S. to discharge a patient with artificial heart

Mayo Clinic Hospital in northeast Phoenix made history on May 3, 2010, when it became the first hospital in the U.S. to discharge a patient with an artificial heart - after he had been hospitalized for more than two years.

25 May 2010

Boston Scientific collaborates with Philips, Siemens to offer integrated imaging systems

Boston Scientific Corporation today announced collaborations with Philips Healthcare and Siemens Medical Solutions to enable the use of its iLab® Ultrasound Imaging System with the Philips Allura™ Xper and the Siemens AXIOM™ Artis and Artis™ zee interventional X-ray systems. Intravascular ultrasound (IVUS) technology is designed to provide physicians a 360-degree view inside the heart and coronary vessels to assist with diagnosis and to generate a more accurate image of the diseased vessels than is possible with angiography alone.

From Philips Healthcare 25 May 2010

DAPT Study expands into seven countries in the EU: HCRI

The Harvard Clinical Research Institute announced today that the DAPT Study has expanded into seven countries in the European Union. John Irving, MBChB, MRCP, M.D., consultant cardiologist at Ninewells Hospital in Dundee, United Kingdom, was the first European investigator to enroll patients into the study.

25 May 2010

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Bayer Inc. today responded to Professor Marvin Meyer's letter to the editor, entitled: "Critical questions concerning the validity of the Bayer study report of differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration" and published in the online edition of the International Journal of Clinical Pharmacology and Therapeutics. Bayer responded to the clinical relevance of the differences in formulation and dissolution behaviour and the delayed absorption of Mylan's extended release nifedipine.

25 May 2010

States struggle with poor dental care

Reports show that California and Wisconsin have poor dental care, while various communities try to improve lagging dental care indicators.

25 May 2010

Researchers examine relationship between visiting primary care physician and effect blood pressure

Frequent doctor visits helped diabetes patients lower their high blood pressure to normal quicker, according to a large study reported in Hypertension: Journal of the American Heart Association.

25 May 2010

Heart Disease News and Research

Latest Heart Disease News and Research

GTx reports top line results from toremifene Phase III clinical trial for prostate cancer

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

St. Jude Medical initiates enrollment in FAME II trial for coronary artery disease

Medtronic fiscal year 2010 revenue up 8% to $15.817 billion

MAQUET Cardiovascular commences enrollment in trial of FUSION and FUSION BIOLINE Vascular Grafts

REDUCE trial data published in the online version of European Urology

Anaheim Regional Medical Center uses Arctic Sun cooling device to protect a patient from brain damage

Hawaii Pacific Health, Saint Barnabas Health Care System and XCelience achieve CEO Cancer Gold Standard

Researchers develop new device that can change current landscape of chronic wound management

Masimo PVI identifies patients at high risk for developing severe hypotension during anesthesia induction

t2c001 product obtains certificate under EMA regulations for ATMPs

Folate supplementation thwarts heart birth defects induced by alcohol exposure in early pregnancy

EHSI reports favorable completion of due diligence with Stand-By Systems

PMI's CAAS software integrated with Ziehm Imaging's mobile cardiovascular imaging solutions

Mayo Clinic becomes first hospital in the U.S. to discharge a patient with artificial heart

Boston Scientific collaborates with Philips, Siemens to offer integrated imaging systems

DAPT Study expands into seven countries in the EU: HCRI

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

States struggle with poor dental care

Researchers examine relationship between visiting primary care physician and effect blood pressure

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Heart Disease News and Research

Latest Heart Disease News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in